Literature DB >> 75240

Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen.

R E Thompson, R Mandle, A P Kaplan.   

Abstract

Human high molecular weight (HMW) kininogen has been isolated and was found to be a single chain protein of approximately equal to 120,000 daltons. Upon digestion with plasma kallikrein bradykinin is generated, and SDS gel electrophoresis of the kinin-free protein reveals an apparent loss in size of 15,000 daltons. The kinin-free kininogen retains full activity as a coagulation factor and consists of two chains: a heavy chain of approximately equal to 66,000 daltons disulfide-linked to a light chain of 37,000 daltons. The heavy chain of HMW kininogen shares antigenic determinants with LMW kininogen and possesses no detectable coagulant activity. The isolated light chain is shown to be responsible for the coagulant activity of HMW kininogen and contains a unique antigenic determinant that distinguishes HMW kininogen from low molecular weight kininogen.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 75240      PMCID: PMC2184499          DOI: 10.1084/jem.147.2.488

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen.

Authors:  R T Matheson; D R Miller; M J Lacombe; Y N Han; S Iwanaga; H Kato; K D wuepper
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

2.  Interaction between factor XII (Hageman factor), high molecular weight kininogen and prekallikrein.

Authors:  J Y Chan; F M Habal; C E Burrowes; H Z Movat
Journal:  Thromb Res       Date:  1976-11       Impact factor: 3.944

3.  Primary structure of bovine plasma high-molecular-weight kininogen. The amino acid sequence of a glycopeptide portion (fragment 1) following the C-terminus ot the bradykinin moiety.

Authors:  Y N Han; H Kato; S Iwanaga; T Suzuki
Journal:  J Biochem       Date:  1976-06       Impact factor: 3.387

4.  Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.

Authors:  C Y Liu; C F Scott; A Bagdasarian; J V Pierce; A P Kaplan; R W Colman
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

5.  Association of factor XI and high molecular weight kininogen in human plasma.

Authors:  R E Thompson; R Mandle; A P Kaplan
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

6.  Guanosine 3':5'-cyclic monophosphate binding proteins in rat tissues.

Authors:  T M Lincoln; C L Hall; C R Park; J D Corbin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

7.  The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.

Authors:  S D Revak; C G Cochrane; J H Griffin
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

8.  Flaujeac trait. Deficiency of human plasma kininogen.

Authors:  K D Wuepper; D R Miller; M J Lacombe
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

9.  Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.

Authors:  R Mandle; A P Kaplan
Journal:  J Biol Chem       Date:  1977-09-10       Impact factor: 5.157

10.  Relationship of contact activation cofactor (CAC) procoagulant activity to kininogen.

Authors:  S Schiffman; P Lee; D I Feinstein; R Pecci
Journal:  Blood       Date:  1977-06       Impact factor: 22.113

View more
  25 in total

Review 1.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

2.  Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).

Authors:  K Joseph; B Ghebrehiwet; E I Peerschke; K B Reid; A P Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

3.  Knockdown of circulating C1 inhibitor induces neurovascular impairment, glial cell activation, neuroinflammation, and behavioral deficits.

Authors:  Dorit Farfara; Emily Feierman; Allison Richards; Alexey S Revenko; Robert A MacLeod; Erin H Norris; Sidney Strickland
Journal:  Glia       Date:  2019-03-18       Impact factor: 7.452

4.  High molecular weight kininogen is an inhibitor of platelet calpain.

Authors:  A H Schmaier; H Bradford; L D Silver; A Farber; C F Scott; D Schutsky; R W Colman
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

5.  Localisation of immunoreactive kininogen and tissue kallikrein in the human nephron.

Authors:  C D Figueroa; A G MacIver; J C Mackenzie; K D Bhoola
Journal:  Histochemistry       Date:  1988

6.  Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.

Authors:  R E Thompson; R Mandle; A P Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

7.  Kallikrein-like activity of crotalase, a snake venom enzyme that clots fibrinogen.

Authors:  F S Markland; C Kettner; S Schiffman; E Shaw; S S Bajwa; K N Reddy; H Kirakossian; G B Patkos; I Theodor; H Pirkle
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Guinea pig plasma kallikrein as a vascular permeability enhancement factor. Its dependence on kinin generation and regulation mechanisms in vivo.

Authors:  T Imamura; T Yamamoto; T Kambara
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

9.  Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.

Authors:  M Maier; K F Austen; J Spragg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

Review 10.  Perspectives for the future.

Authors:  E F Mammen
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.